Movatterモバイル変換

[0]ホーム
URL:

GB2013084B - Ophthalmic drug dosage - Google Patents

Ophthalmic drug dosage

Info

Publication number
GB2013084B
GB2013084BGB7845835AGB7845835AGB2013084BGB 2013084 BGB2013084 BGB 2013084BGB 7845835 AGB7845835 AGB 7845835AGB 7845835 AGB7845835 AGB 7845835AGB 2013084 BGB2013084 BGB 2013084B
Authority
GB
United Kingdom
Prior art keywords
drug dosage
ophthalmic drug
ophthalmic
dosage
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7845835A
Other versions
GB2013084A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories IncfiledCriticalAlcon Laboratories Inc
Publication of GB2013084ApublicationCriticalpatent/GB2013084A/en
Application grantedgrantedCritical
Publication of GB2013084BpublicationCriticalpatent/GB2013084B/en
Expiredlegal-statusCriticalCurrent

Links

Classifications

Landscapes

GB7845835A1978-01-251978-11-23Ophthalmic drug dosageExpiredGB2013084B (en)

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
US87207478A1978-01-251978-01-25

Publications (2)

Publication NumberPublication Date
GB2013084A GB2013084A (en)1979-08-08
GB2013084Btrue GB2013084B (en)1982-07-28

Family

ID=25358780

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB7845835AExpiredGB2013084B (en)1978-01-251978-11-23Ophthalmic drug dosage

Country Status (7)

CountryLink
JP (2)JPS6059885B2 (en)
CA (1)CA1108053A (en)
CH (1)CH640737A5 (en)
DE (1)DE2902863C2 (en)
FR (1)FR2415459A1 (en)
GB (1)GB2013084B (en)
MX (1)MX6520E (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4347238A (en)1979-10-261982-08-31Smith & Nephew Associated Companies LimitedAutoclavable emulsion containing silver sulphadiazine

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB2075837B (en)*1980-05-141984-03-14Hisamitsu Pharmaceutical CoTopical pharmaceutical gel containing anti-inflammatory analgesic agents
GB8500310D0 (en)*1985-01-071985-02-13Leo Pharm Prod LtdPharmaceutical preparation
US6255299B1 (en)1985-01-072001-07-03Leo Pharmaceutical Products Ltd.Opthalmic gel composition and method of treating eye infections
US5188826A (en)*1988-02-081993-02-23Insite Vision IncorporatedTopical ophthalmic suspensions
US5192535A (en)*1988-02-081993-03-09Insite Vision IncorporatedOphthalmic suspensions
US5124154A (en)*1990-06-121992-06-23Insite Vision IncorporatedAminosteroids for ophthalmic use
JP2873530B2 (en)*1991-12-131999-03-24参天製薬株式会社 Carboxyvinyl polymer-containing ophthalmic base showing Newtonian viscosity
CN1049358C (en)*1993-01-012000-02-16参天制药株式会社Carboxybinil polymer which shows newtonian viscosity
US5340572A (en)*1993-02-081994-08-23Insite Vision IncorporatedAlkaline ophthalmic suspensions
MX9603858A (en)1994-03-041997-12-31Univ WashingtonBlock and graft copolymers and methods relating thereto.
US5683709A (en)*1994-05-051997-11-04Ciba Vision CorporationPoly(benzalkonium salt) as an anti-microbial agent for aqueous drug compositions
DE19614823A1 (en)*1996-04-151997-10-16Mann Gerhard Chem Pharm Fab Ophthalmic composition with prolonged retention time on the eye
DE60003074T2 (en)1999-10-152004-03-18Leo Pharmaceutical Products Ltd. A/S (Loevens Kemiske Fabrik Produktionsaktieselskab) Fusidic DERIVATIVES
WO2005014046A2 (en)*2003-08-072005-02-17Allergan, Inc.Compositions for delivery of therapeutics into the eyes and methods for making and using the same
DE102010009475B4 (en)2010-02-262011-11-24F. Holzer Gmbh Process for the preparation of a dosable ready-to-use preparation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
CA1012060A (en)*1964-10-061977-06-14Gilman N. CyrDimethyl sulfoxide gel preparations
FR2038105A1 (en)*1969-04-011971-01-08Syntex CorpAntiinflammatory steroid preparations
DK135267A (en)*1971-02-25
DE2239206A1 (en)*1971-08-121973-03-15Hydrophilics Int Inc COPOLYMER
US3957740A (en)*1972-04-241976-05-18Hydrophilics International, Inc.Copolymers
FR2191941A1 (en)*1972-07-101974-02-08Serabonian GiacomoGelatinising water-sol and aq liqs - by addn of carboxypolymer and alginic acid salt
DE2265164C3 (en)*1972-10-181985-08-22Vsesojuznyj naučno-issledovatel'skij i ispytatel'nyj institut medicinskoj techniki, Moskau/Moskva Use of acrylic acid amide copolymers for the production of bases for ophthalmic drug forms
AR206692A1 (en)*1972-12-271976-08-13Alza Corp DISPENSING AGENT OF SUSTAINED RELEASE OF ACTIVE SUBSTANCES
LU70487A1 (en)*1974-07-081976-05-31
US4003991A (en)*1974-08-271977-01-18National Patent Development CorporationOphthalmic formulation
JPS5138412A (en)*1974-09-241976-03-31Nippon Kayaku KkKokoseizai no seiho
IL50250A (en)*1975-08-271980-01-31Hydrophilics Int IncSustained release compositions comprising slats of pharmaceutically acitve bases with polymers containing acid groups
JPS6056684B2 (en)*1977-11-071985-12-11東興薬品工業株式会社 eye drops

Cited By (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4347238A (en)1979-10-261982-08-31Smith & Nephew Associated Companies LimitedAutoclavable emulsion containing silver sulphadiazine

Also Published As

Publication numberPublication date
JPS6059885B2 (en)1985-12-27
FR2415459A1 (en)1979-08-24
JPS54110312A (en)1979-08-29
JPS62215518A (en)1987-09-22
DE2902863A1 (en)1979-07-26
MX6520E (en)1985-06-27
CH640737A5 (en)1984-01-31
GB2013084A (en)1979-08-08
JPH0428244B2 (en)1992-05-13
DE2902863C2 (en)1994-02-24
CA1108053A (en)1981-09-01
FR2415459B1 (en)1983-03-18

Similar Documents

PublicationPublication DateTitle
US4295567B1 (en)Medicament container
JPS567714A (en)Pharmaceutical medicine
GB2085732B (en)Administration set
AU513845B2 (en)Pharmaceutical dosage forms
AU521053B2 (en)Medicament dosage form
IL58209A0 (en)Medicament inhaler
MY8500567A (en)Removable drug implant
JPS55147223A (en)Pharmaceutical medicine
GB2013084B (en)Ophthalmic drug dosage
ZA796549B (en)New pharmaceutical preparations
GB2020655B (en)Pharmaceutical compounds
ZA787000B (en)Pharmaceutical formulation
JPS54157817A (en)Pharmaceutical prepared solution
JPS54132563A (en)Corticosteroid antiiinflammatry drug
ZA793923B (en)Medicinal formulation
JPS54141797A (en)Therapeutic drug
JPS5524175A (en)Agricultural drug
JPS54135795A (en)Diuretic drug
GB2039739B (en)Medicament against glaucoma
JPS5527168A (en)Drug composition
JPS5519257A (en)Medicine retard form
ZA793928B (en)Medicinal formulation
JPS5555114A (en)Fine drug
GB2028660B (en)Administration set
RO77521A2 (en) ANTIRHUMATISMAL DRUG

Legal Events

DateCodeTitleDescription
PE20Patent expired after termination of 20 years

Effective date:19981122
[8]ページ先頭
©2009-2025 Movatter.jp